These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3667890)

  • 21. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dietary calcium on stone forming propensity.
    Heller HJ; Doerner MF; Brinkley LJ; Adams-Huet B; Pak CY
    J Urol; 2003 Feb; 169(2):470-4. PubMed ID: 12544289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients.
    Baxmann AC; De O G Mendonça C; Heilberg IP
    Kidney Int; 2003 Mar; 63(3):1066-71. PubMed ID: 12631089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited risk of kidney stone formation during long-term calcium citrate supplementation in nonstone forming subjects.
    Sakhaee K; Baker S; Zerwekh J; Poindexter J; Garcia-Hernandez PA; Pak CY
    J Urol; 1994 Aug; 152(2 Pt 1):324-7. PubMed ID: 8015062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
    Preminger GM; Sakhaee K; Pak CY
    J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise.
    Okada A; Ohshima H; Itoh Y; Yasui T; Tozawa K; Kohri K
    Int J Urol; 2008 Jul; 15(7):630-5. PubMed ID: 18479353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors for the formation of urinary calcium-containing stones in diabetics].
    Liu JG; Hu M; He XQ
    Zhonghua Nei Ke Za Zhi; 1989 Nov; 28(11):649-53, 699-700. PubMed ID: 2632175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxypurines, protein, glucose and the functional state of blood vasculature are markers of renal calcium stone-forming processes? Observations in men with idiopathic recurrent calcium urolithiasis.
    Manoharan M; Schwille PO
    Clin Chem Lab Med; 2002 Mar; 40(3):266-77. PubMed ID: 12005217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1223-5. PubMed ID: 4055988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
    Pylypchuk G; Ehrig U; Wilson DR
    Can Med Assoc J; 1979 Mar; 120(6):658-65. PubMed ID: 436047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in 24-hour urine composition between apatite and brushite stone formers.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery.
    Sakhaee K; Griffith C; Pak CY
    Surg Obes Relat Dis; 2012; 8(1):67-72. PubMed ID: 21703942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the physicochemical risk for renal stone disease during pregnancy.
    Smith CL; Kristensen C; Davis M; Abraham PA
    Clin Nephrol; 2001 Mar; 55(3):205-11. PubMed ID: 11316240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.